The Efficacy of Platelet-Rich Plasma for Improving Pain and Function in Lateral Epicondylitis: A Systematic Review and Meta-analysis with Risk-of-Bias Assessment


      To assess the efficacy of platelet-rich plasma (PRP) for lateral epicondylitis and evaluate its impact on pain and functional outcomes.


      This study followed Preferred Reporting Items and Systematic Reviews and Meta-Analyses guidelines. A comprehensive literature search was conducted in September 2019 and repeated in April 2020 using electronic databases PubMed, MEDLINE, and the Cochrane Library. Baseline and 3-, 6-, and 12-month data were extracted for visual analog scale (VAS), Disabilities of the Arm, Shoulder, and Hand (DASH), and modified Mayo Clinic performance index for the elbow (MAYO) scores. Only level 1 studies with patients who had not undergone surgery were included. Outcomes data, study design, demographic variables, PRP formulation, and comparator treatments were recorded. Statistical analyses of pooled weighted mean differences (WMDs) were performed and compared with estimated minimal clinically important difference (MCID) values. The Coleman Methodology Score (CMS) was used to assess methodological quality, and the Cochrane risk-of-bias assessment was performed.


      This review included 16 level I studies, 9 of which (581 total patients, 281 receiving single injections of PRP) were quantitatively analyzed. The average age was 41.5 years, 56.8% of patients were female, and mean follow-up was 7.5 months. The mean CMS was 78.94 ± 12.74 (range 59 to 97), and 5 of 16 studies were at low risk for bias. Patients who received PRP had significantly improved VAS scores at 3 months (WMD –0.85; 95% confidence interval [CI] –1.03, –0.66; P < .01) and 6 months (WMD –0.74; 95% CI –0.98, –0.50; P < .01) compared with those who received autologous whole blood, though MAYO scores were statistically equivalent. Comparing PRP to corticosteroids, VAS and DASH scores were not significantly different at 3 months, although PRP was superior at 6 months for VAS (WMD –1.70; 95% CI –2.65, –0.75; P < .01) and DASH (WMD –6.23; 95% CI –10.78, –1.69; P < .01). Most differences in VAS and DASH scores exceeded the 5% absolute difference estimate for their respective MCIDs but fell short of the 10% estimate.


      Considering the small number of comparable studies, lack of quantification of specific PRP content, considerable heterogeneity between randomized control trials, and most effect sizes being equivocal within the framework of 2 estimated MCID values, the authors can neither scientifically support nor discourage the usage of PRP for lateral epicondylitis despite finding statistically significant improvements in pain and functional outcomes.

      Level of Evidence

      I, prognostic.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Buchanan B.K.
        • Varacallo M.
        Tennis elbow.
        StatPearls. StatPearls Publishing, 2020
        • Degen R.M.
        • Conti M.S.
        • Camp C.L.
        • Altchek D.W.
        • Dines J.S.
        • Werner B.C.
        Epidemiology and disease burden of lateral epicondylitis in the USA: Analysis of 85,318 patients.
        HSS J. 2018; 14: 9-14
        • Pattanittum P.
        • Turner T.
        • Green S.
        • Buchbinder R.
        Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults.
        Cochrane Database Syst Rev. 2013; : CD003686
        • Viswas R.
        • Ramachandran R.
        • Korde Anantkumar P.
        Comparison of effectiveness of supervised exercise program and Cyriax physiotherapy in patients with tennis elbow (lateral epicondylitis): A randomized clinical trial.
        Sci World J. 2012; 2012: 939645
        • Altan L.
        • Kanat E.
        Conservative treatment of lateral epicondylitis: Comparison of two different orthotic devices.
        Clin Rheumatol. 2008; 27: 1015-1019
        • Bostrøm K.
        • Mæhlum S.
        • Cvancarova Småstuen M.
        • Storheim K.
        Clinical comparative effectiveness of acupuncture versus manual therapy treatment of lateral epicondylitis: Feasibility randomized clinical trial.
        Pilot Feasibility Stud. 2019; 5: 110
        • Burn M.B.
        • Mitchell R.J.
        • Liberman S.R.
        • Lintner D.M.
        • Harris J.D.
        • McCulloch P.C.
        Open, arthroscopic, and percutaneous surgical treatment of lateral epicondylitis: A systematic review.
        Hand. 2018; 13: 264-274
        • Haake M.
        • König I.R.
        • Decker T.
        • et al.
        Extracorporeal shock wave therapy in the treatment of lateral epicondylitis: A randomized multicenter trial.
        J Bone Joint Surg Am. 2002; 84: 1982-1991
        • Melikyan E.Y.
        • Shahin E.
        • Miles J.
        • Bainbridge L.C.
        Extracorporeal shock-wave treatment for tennis elbow. A randomised double-blind study.
        J Bone Joint Surg Br. 2003; 85: 852-855
        • Smidt N.
        • van der Windt D.A.W.M.
        • Assendelft W.J.J.
        • Devillé W.L.J.M.
        • Korthals-de Bos I.B.C.
        • Bouter L.M.
        Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: A randomised controlled trial.
        Lancet. 2002; 359: 657-662
        • Calandruccio J.H.
        • Steiner M.M.
        Autologous blood and platelet-rich plasma injections for treatment of lateral epicondylitis.
        Orthop Clin North Am. 2017; 48: 351-357
        • Andres B.M.
        • Murrell G.A.C.
        Treatment of tendinopathy: What works, what does not, and what is on the horizon.
        Clin Orthop Relat Res. 2008; 466: 1539-1554
        • Le A.D.K.
        • Enweze L.
        • DeBaun M.R.
        • Dragoo J.L.
        Platelet-rich plasma.
        Clin Sports Med. 2019; 38: 17-44
        • Boswell S.G.
        • Cole B.J.
        • Sundman E.A.
        • Karas V.
        • Fortier L.A.
        Platelet-rich plasma: A milieu of bioactive factors.
        Arthroscopy. 2012; 28: 429-439
        • Amable P.R.
        • Carias R.B.V.
        • Teixeira M.V.T.
        • et al.
        Platelet-rich plasma preparation for regenerative medicine: Optimization and quantification of cytokines and growth factors.
        Stem Cell Res Ther. 2013; 4: 67
        • Kajikawa Y.
        • Morihara T.
        • Sakamoto H.
        • et al.
        Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing.
        J Cell Physiol. 2008; 215: 837-845
        • Dohan Ehrenfest D.M.
        • Andia I.
        • Zumstein M.A.
        • Zhang C.-Q.
        • Pinto N.R.
        • Bielecki T.
        Classification of platelet concentrates (platelet-rich plasma-PRP, platelet-rich fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: Current consensus, clinical implications and perspectives.
        Muscles Ligaments Tendons J. 2014; 4: 3-9
        • Mishra A.
        • Harmon K.
        • Woodall J.
        • Vieira A.
        Sports medicine applications of platelet rich plasma.
        Curr Pharm Biotechnol. 2012; 13: 1185-1195
        • Mishra A.K.
        • Skrepnik N.V.
        • Edwards S.G.
        • et al.
        Efficacy of platelet-rich plasma for chronic tennis elbow: A double-blind, prospective, multicenter, randomized controlled trial of 230 patients.
        Am J Sports Med. 2014; 42: 463-471
        • Gosens T.
        • Peerbooms J.C.
        • van Laar W.
        • den Oudsten B.L.
        Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: A double-blind randomized controlled trial with 2-year follow-up.
        Am J Sports Med. 2011; 39: 1200-1208
        • Chen X.
        • Jones I.A.
        • Park C.
        • Vangsness Jr., C.T.
        The efficacy of platelet-rich plasma on tendon and ligament healing: A systematic review and meta-analysis with bias assessment.
        Am J Sports Med. 2018; 46: 2020-2032
        • Dong W.
        • Goost H.
        • Lin X.-B.
        • et al.
        Injection therapies for lateral epicondylalgia: A systematic review and Bayesian network meta-analysis.
        Br J Sports Med. 2016; 50: 900-908
        • Krogh T.P.
        • Bartels E.M.
        • Ellingsen T.
        • et al.
        Comparative effectiveness of injection therapies in lateral epicondylitis: A systematic review and network meta-analysis of randomized controlled trials.
        Am J Sports Med. 2013; 41: 1435-1446
        • Arirachakaran A.
        • Sukthuayat A.
        • Sisayanarane T.
        • Laoratanavoraphong S.
        • Kanchanatawan W.
        • Kongtharvonskul J.
        Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: Systematic review and network meta-analysis.
        J Orthop Traumatol. 2016; 17: 101-112
        • Mi B.
        • Liu G.
        • Zhou W.
        • et al.
        Platelet rich plasma versus steroid on lateral epicondylitis: Meta-analysis of randomized clinical trials.
        Phys Sports Med. 2017; 45: 97-104
        • Tang S.
        • Wang X.
        • Wu P.
        • et al.
        Platelet-rich plasma vs autologous blood vs corticosteroid injections in the treatment of lateral epicondylitis: A systematic review, pairwise and network meta-analysis of randomized controlled trials.
        PM R. 2020; 12: 397-409
        • Xu Q.
        • Chen J.
        • Cheng L.
        Comparison of platelet rich plasma and corticosteroids in the management of lateral epicondylitis: A meta-analysis of randomized controlled trials.
        Int J Surg. 2019; 67: 37-46
        • Tonin F.S.
        • Rotta I.
        • Mendes A.M.
        • Pontarolo R.
        Network meta-analysis: A technique to gather evidence from direct and indirect comparisons.
        Pharm Pract. 2017; 15: 943
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • PRISMA Group
        Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.
        Int J Surg. 2010; 8: 336-341
        • Stewart L.A.
        • Clarke M.
        • Rovers M.
        • et al.
        Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: The PRISMA-IPD Statement.
        JAMA. 2015; 313: 1657-1665
        • Coleman B.D.
        • Khan K.M.
        • Maffulli N.
        • Cook J.L.
        • Wark J.D.
        Studies of surgical outcome after patellar tendinopathy: Clinical significance of methodological deficiencies and guidelines for future studies. Victorian Institute of Sport Tendon Study Group.
        Scand J Med Sci Sports. 2000; 10: 2-11
        • Tallon C.
        • Coleman B.D.
        • Khan K.M.
        • Maffulli N.
        Outcome of surgery for chronic Achilles tendinopathy. A critical review.
        Am J Sports Med. 2001; 29: 315-320
        • Mithoefer K.
        • McAdams T.
        • Williams R.J.
        • Kreuz P.C.
        • Mandelbaum B.R.
        Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis.
        Am J Sports Med. 2009; 37: 2053-2063
        • Liberati A.
        • Altman D.G.
        • Tetzlaff J.
        • et al.
        The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration.
        PLoS Med. 2009; 6e1000100
        • Price D.D.
        • McGrath P.A.
        • Rafii A.
        • Buckingham B.
        The validation of visual analogue scales as ratio scale measures for chronic and experimental pain.
        Pain. 1983; 17: 45-56
        • Cusick M.C.
        • Bonnaig N.S.
        • Azar F.M.
        • Mauck B.M.
        • Smith R.A.
        • Throckmorton T.W.
        Accuracy and reliability of the Mayo Elbow Performance Score.
        J Hand Surg Am. 2014; 39: 1146-1150
        • Gummesson C.
        • Atroshi I.
        • Ekdahl C.
        The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: Longitudinal construct validity and measuring self-rated health change after surgery.
        BMC Musculoskelet Disord. 2003; 4: 11
        • Jevsevar D.S.
        Treatment of osteoarthritis of the knee: Evidence-based guideline.
        J Am Acad Orthop Surg. 2013; 21 (2nd edition): 571-576
        • Jones I.A.
        • Togashi R.
        • Heckmann N.
        • Vangsness Jr., C.T.
        Minimal clinically important difference (MCID) for patient-reported shoulder outcomes.
        J Shoulder Elbow Surg. 2020; 29: 1484-1492
        • Tashjian R.Z.
        • Hung M.
        • Keener J.D.
        • et al.
        Determining the minimal clinically important difference for the American Shoulder and Elbow Surgeons score, Simple Shoulder Test, and visual analog scale (VAS) measuring pain after shoulder arthroplasty.
        J Shoulder Elbow Surg. 2017; 26: 144-148
        • Tashjian R.Z.
        • Deloach J.
        • Porucznik C.A.
        • Powell A.P.
        Minimal clinically important differences (MCID) and patient acceptable symptomatic state (PASS) for visual analog scales (VAS) measuring pain in patients treated for rotator cuff disease.
        J Shoulder Elbow Surg. 2009; 18: 927-932
        • Franchignoni F.
        • Vercelli S.
        • Giordano A.
        • Sartorio F.
        • Bravini E.
        • Ferriero G.
        Minimal clinically important difference of the disabilities of the arm, shoulder and hand outcome measure (DASH) and its shortened version (QuickDASH).
        J Orthop Sports Phys Ther. 2014; 44: 30-39
        • Sorensen A.A.
        • Howard D.
        • Tan W.H.
        • Ketchersid J.
        • Calfee R.P.
        Minimal clinically important differences of 3 patient-rated outcomes instruments.
        J Hand Surg Am. 2013; 38: 641-649
        • Lee J.S.
        • Hobden E.
        • Stiell I.G.
        • Wells G.A.
        Clinically important change in the visual analog scale after adequate pain control.
        Acad Emerg Med. 2003; 10: 1128-1130
        • Simovitch R.
        • Flurin P.-H.
        • Wright T.
        • Zuckerman J.D.
        • Roche C.P.
        Quantifying success after total shoulder arthroplasty: The minimal clinically important difference.
        J Shoulder Elbow Surg. 2018; 27: 298-305
        • Johnston B.C.
        • Thorlund K.
        • Schünemann H.J.
        • et al.
        Improving the interpretation of quality of life evidence in meta-analyses: The application of minimal important difference units.
        Health Qual Life Outcomes. 2010; 8: 116
        • Peerbooms J.C.
        • Sluimer J.
        • Bruijn D.J.
        • Gosens T.
        Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up.
        Am J Sports Med. 2010; 38: 255-262
        • Montalvan B.
        • Le Goux P.
        • Klouche S.
        • Borgel D.
        • Hardy P.
        • Breban M.
        Inefficacy of ultrasound-guided local injections of autologous conditioned plasma for recent epicondylitis: Results of a double-blind placebo-controlled randomized clinical trial with one-year follow-up.
        Rheumatology. 2016; 55: 279-285
        • Krogh T.P.
        • Fredberg U.
        • Stengaard-Pedersen K.
        • Christensen R.
        • Jensen P.
        • Ellingsen T.
        Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: A randomized, double-blind, placebo-controlled trial.
        Am J Sports Med. 2013; 41: 625-635
        • Creaney L.
        • Wallace A.
        • Curtis M.
        • Connell D.
        Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: A prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections.
        Br J Sports Med. 2011; 45: 966-971
        • Biau D.J.
        • Kernéis S.
        • Porcher R.
        Statistics in brief: The importance of sample size in the planning and interpretation of medical research.
        Clin Orthop Relat Res. 2008; 466: 2282-2288
        • Behera P.
        • Dhillon M.
        • Aggarwal S.
        • Marwaha N.
        • Prakash M.
        Leukocyte-poor platelet-rich plasma versus bupivacaine for recalcitrant lateral epicondylar tendinopathy.
        J Orthop Surg. 2015; 23: 6-10
        • Gautam V.K.
        • Verma S.
        • Batra S.
        • Bhatnagar N.
        • Arora S.
        Platelet-rich plasma versus corticosteroid injection for recalcitrant lateral epicondylitis: Clinical and ultrasonographic evaluation.
        J Orthop Surg. 2015; 23: 1-5
        • Tetschke E.
        • Rudolf M.
        • Lohmann C.H.
        • Stärke C.
        Autologous proliferative therapies in recalcitrant lateral epicondylitis.
        Am J Phys Med Rehabil. 2015; 94: 696-706
        • Lebiedziński R.
        • Synder M.
        • Buchcic P.
        • Polguj M.
        • Grzegorzewski A.
        • Sibiński M.
        A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis.
        Int Orthop. 2015; 39: 2199-2203
        • Omar A.S.
        • Ibrahim M.E.
        • Ahmed A.S.
        • Said M.
        Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: Randomized clinical trial.
        Egypt Rheumatol. 2012; 34: 43-49
        • Yadav R.
        • Kothari S.Y.
        • Borah D.
        Comparison of local injection of platelet rich plasma and corticosteroids in the treatment of lateral epicondylitis of humerus.
        J Clin Diagn Res. 2015; 9: RC05-RC07
        • Khaliq A.
        • Khan I.
        • Inam M.
        • Saeed M.
        • Khan H.
        • Iqbal M.J.
        Effectiveness of platelets rich plasma versus corticosteroids in lateral epicondylitis.
        J Pak Med Assoc. 2015; 65: S100-S104
        • Palacio E.P.
        • Schiavetti R.R.
        • Kanematsu M.
        • Ikeda T.M.
        • Mizobuchi R.R.
        • Galbiatti J.A.
        Effects of platelet-rich plasma on lateral epicondylitis of the elbow: Prospective randomized controlled trial.
        Rev Bras Ortop. 2016; 51: 90-95
        • Raeissadat S.A.
        • Rayegani S.M.
        • Hassanabadi H.
        • Rahimi R.
        • Sedighipour L.
        • Rostami K.
        Is platelet-rich plasma superior to whole blood in the management of chronic tennis elbow: One year randomized clinical trial.
        BMC Sports Sci Med Rehabil. 2014; 6: 12
        • Raeissadat S.A.
        • Sedighipour L.
        • Rayegani S.M.
        • Bahrami M.H.
        • Bayat M.
        • Rahimi R.
        Effect of platelet-rich plasma (PRP) versus autologous whole blood on pain and function improvement in tennis elbow: A randomized clinical trial.
        Pain Res Treat. 2014; 2014: 191525
        • Thanasas C.
        • Papadimitriou G.
        • Charalambidis C.
        • Paraskevopoulos I.
        • Papanikolaou A.
        Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial.
        Am J Sports Med. 2011; 39: 2130-2134
        • Haahr J.P.
        • Andersen J.H.
        Prognostic factors in lateral epicondylitis: A randomized trial with one-year follow-up in 266 new cases treated with minimal occupational intervention or the usual approach in general practice.
        Rheumatology. 2003; 42: 1216-1225
        • Chen X.
        • Jones I.A.
        • Togashi R.
        • Park C.
        • Vangsness Jr., C.T.
        Use of platelet-rich plasma for the improvement of pain and function in rotator cuff tears: A systematic review and meta-analysis with bias assessment.
        Am J Sports Med. 2020; 48: 2028-2041
        • Zhang Y.-J.
        • Xu S.-Z.
        • Gu P.-C.
        • et al.
        Is platelet-rich plasma injection effective for chronic Achilles tendinopathy? A meta-analysis.
        Clin Orthop Relat Res. 2018; 476: 1633-1641
        • Jones I.A.
        • Togashi R.
        • Wilson M.L.
        • Heckmann N.
        • Vangsness Jr., C.T.
        Intra-articular treatment options for knee osteoarthritis.
        Nat Rev Rheumatol. 2019; 15: 77-90
        • Wright A.
        • Hannon J.
        • Hegedus E.J.
        • Kavchak A.E.
        Clinimetrics corner: A closer look at the minimal clinically important difference (MCID).
        J Man Manip Ther. 2012; 20: 160-166
        • Dworkin R.H.
        • Turk D.C.
        • Wyrwich K.W.
        • et al.
        Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
        J Pain. 2008; 9: 105-121
        • Gao B.
        • Dwivedi S.
        • DeFroda S.
        • et al.
        The therapeutic benefits of saline solution injection for lateral epicondylitis: A meta-analysis of randomized controlled trials comparing saline injections with nonsurgical injection therapies.
        Arthroscopy. 2019; 35: 1847-1859.e12
        • Martin R.L.
        • Kivlan B.R.
        • Christoforetti J.J.
        • et al.
        Minimal clinically important difference and substantial clinical benefit values for a pain visual analog scale after hip arthroscopy.
        Arthroscopy. 2019; 35: 2064-2069
        • Danoff J.R.
        • Goel R.
        • Sutton R.
        • Maltenfort M.G.
        • Austin M.S.
        How much pain is significant? Defining the minimal clinically important difference for the visual analog scale for pain after total joint arthroplasty.
        J Arthroplasty. 2018; 33: S71-S75.e2
        • Murray I.R.
        • Geeslin A.G.
        • Goudie E.B.
        • Petrigliano F.A.
        • LaPrade R.F.
        Minimum information for studies evaluating biologics in orthopaedics (MIBO): Platelet-rich plasma and mesenchymal stem cells.
        J Bone Joint Surg Am. 2017; 99: 809-819
        • Chahla J.
        • Cinque M.E.
        • Piuzzi N.S.
        • et al.
        A call for standardization in platelet-rich plasma preparation protocols and composition reporting: A systematic review of the clinical orthopaedic literature.
        J Bone Joint Surg Am. 2017; 99: 1769-1779
        • Rinnovati R.
        • Romagnoli N.
        • Gentilini F.
        • Lambertini C.
        • Spadari A.
        The influence of environmental variables on platelet concentration in horse platelet-rich plasma.
        Acta Vet Scand. 2016; 58: 45
        • Fitzpatrick J.
        • Bulsara M.
        • Zheng M.H.
        The effectiveness of platelet-rich plasma in the treatment of tendinopathy: A meta-analysis of randomized controlled clinical trials.
        Am J Sports Med. 2017; 45: 226-233
        • Mannava S.
        • Whitney K.E.
        • Kennedy M.I.
        • et al.
        The influence of naproxen on biological factors in leukocyte-rich platelet-rich plasma: A prospective comparative study.
        Arthroscopy. 2019; 35: 201-210
        • Schippinger G.
        • Prüller F.
        • Divjak M.
        • et al.
        Autologous platelet-rich plasma preparations: Influence of nonsteroidal anti-inflammatory drugs on platelet function.
        Orthop J Sports Med. 2015; 3 (2325967115588896)
        • Kikuchi N.
        • Yoshioka T.
        • Taniguchi Y.
        • et al.
        Optimization of leukocyte-poor platelet-rich plasma preparation: A validation study of leukocyte-poor platelet-rich plasma obtained using different preparer, storage, and activation methods.
        J Exp Orthop. 2019; 6: 24
        • Cavallo C.
        • Roffi A.
        • Grigolo B.
        • et al.
        Platelet-rich plasma: The choice of activation method affects the release of bioactive molecules.
        Biomed Res Int. 2016; 2016 (6591717)
        • Karkhanis S.
        • Frost A.
        • Maffulli N.
        Operative management of tennis elbow: A quantitative review.
        Br Med Bull. 2008; 88: 171-188
        • Andriolo L.
        • Altamura S.A.
        • Reale D.
        • Candrian C.
        • Zaffagnini S.
        • Filardo G.
        Nonsurgical treatments of patellar tendinopathy: Multiple injections of platelet-rich plasma are a suitable option: A systematic review and meta-analysis.
        Am J Sports Med. 2019; 47: 1001-1018
        • MacMahon P.J.
        • Eustace S.J.
        • Kavanagh E.C.
        Injectable corticosteroid and local anesthetic preparations: A review for radiologists.
        Radiology. 2009; 252: 647-661
        • Daniels E.W.
        • Cole D.
        • Jacobs B.
        • Phillips S.F.
        Existing evidence on ultrasound-guided injections in sports medicine.
        Orthop J Sports Med. 2018; 6 (2325967118756576)